Trial · NCT07909070
A Study to Investigate the Pharmacokinetics of JMKX003142 in Healthy Participants and Participants With Hepatic Impairment
NCT07909070, Phase 1, Not yet recruiting, Jemincare
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. A Study to Investigate the Pharmacokinetics of JMKX003142 in Healthy Participants and Participants With Hepatic Impairment. Trials, record NCT07909070. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07909070
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Study to Investigate the Pharmacokinetics of JMKX003142 in Healthy Participants and Participants With Hepatic Impairment
- NCT number
- NCT07909070
- Status
- Not yet recruiting
- Phases
- Phase 1
- Enrollment
- 32 participants, estimated
- Lead sponsor
- Jemincare
- Conditions
- ADPKD (Autosomal Dominant Polycystic Kidney Disease), Renal Edema
- Interventions
- JMKX003142
- First posted
- 2026-11-02
- Last updated
- 2026-11-02
Source ClinicalTrials.gov
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | PK parameter Cmax | Predose up to 6 days postdose | maximum observed plasma concentration |
| Primary | PK parameters AUC0-t | Predose up to 6 days postdose | area under the curve from time zero to the specified time point |
| Primary | PK parameters AUC0-inf | Predose up to 6 days postdose | area under the curve from time Zero extrapolated to Infinity |
| Primary | PK parameters Cmax, u | Predose up to 6 days postdose | unbound maximum plasma concentration |
| Primary | PK parameters AUC0-t, u | Predose up to 6 days postdose | area under the unbound concentration-time curve from time zero to the specified time point |
| Primary | PK parameters AUC0-inf, u | Predose up to 6 days postdose | area under the unbound concentration-time curve curve from time Zero extrapolated to Infinity |
| Secondary | PK parameters tmax | Predose up to 6 days postdose | time to reach maximum observed plasma concentration |
| Secondary | PK Parameters t1/2 | Predose up to 6 days postdose | terminal phase half-life |
| Secondary | PK Parameters Vz/F | Predose up to 6 days postdose | apparent volume of distribution |
| Secondary | PK Parameters CL/F | Predose up to 6 days postdose | apparent clearance |
1 to 10 of 13Source ClinicalTrials.gov
See all 13 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07909070
GET https://conductscience.org/api/trials/v1/NCT07909070/registered